Kiniksa Pharmaceuticals, Ltd. - (KNSA) Social Stream
KINIKSA PHARMACEUTICALS LTD (KNSA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering KINIKSA PHARMACEUTICALS LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-28 | 3 | $37 | $26 | $30 | $16.33 | 83.71% |
| 2021-12-29 | 3 | $34 | $25.91 | $28.97 | $16.33 | 77.4% |
| 2022-02-22 | 3 | $34 | $27 | $29.666 | $16.33 | 81.67% |
| 2022-05-03 | 3 | $28 | $24 | $25.666 | $16.33 | 57.17% |
| 2022-08-03 | 3 | $28 | $22 | $25 | $16.33 | 53.09% |
| 2022-10-31 | 3 | $28 | $19 | $24 | $16.33 | 46.97% |
| 2023-02-08 | 3 | $28 | $19 | $24.333 | $16.33 | 49.01% |
| 2023-02-28 | 2 | $28 | $19 | $24.333 | $16.33 | 49.01% |
| 2023-03-03 | 2 | $28 | $19 | $22.333 | $16.33 | 36.76% |
| 2023-05-02 | 3 | $28 | $20 | $22.666 | $16.33 | 38.8% |
| 2023-07-25 | 3 | $28 | $20 | $23 | $16.33 | 40.85% |
| 2023-07-26 | 4 | $32 | $20 | $25.75 | $16.33 | 57.69% |
| 2023-08-09 | 4 | $32 | $23 | $26.75 | $16.33 | 63.81% |
The Trend in the Analyst Price Target
Over the past 31 months, KNSA's average price target has gone down $7.25.
KNSA reports an average of 67.55% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-31 | 3 | 28 | 19 | 24.000 | 11.420 | 110.16% |
| 2022-11-04 | 3 | 28 | 19 | 24.333 | 13.895 | 75.12% |
| 2022-11-09 | 3 | 28 | 19 | 24.333 | 14.890 | 63.42% |
| 2023-02-08 | 3 | 28 | 19 | 24.333 | 13.770 | 76.71% |
| 2023-06-06 | 3 | 28 | 20 | 23.000 | 15.190 | 51.42% |
KNSA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 52 weeks, KNSA's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KNSA as an investment opportunity.
- KINIKSA PHARMACEUTICALS LTD's number of analysts covering the stock is higher than 128.26% of all US stocks.
- KNSA has a lower variance in analysts' estimates than -196.92% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, KINIKSA PHARMACEUTICALS LTD's upside potential (average analyst target price relative to current price) is higher than 409.04% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, KINIKSA PHARMACEUTICALS LTD's average analyst price target is higher than 974.05% of them.
Stocks similar to KINIKSA PHARMACEUTICALS LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are EOLS, OPTN, and SPRO.
View All Top Stocks by Price Target
Is KNSA a Buy, Hold or Sell? See the POWR Ratings now!